Follow
Tianyi Chen
Tianyi Chen
Verified email at utoronto.ca
Title
Cited by
Cited by
Year
Epithelial splicing regulatory protein 2–mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis
J Hyun, Z Sun, AR Ahmadi, S Bangru, UV Chembazhi, K Du, T Chen, ...
The Journal of clinical investigation 130 (4), 2129-2145, 2020
532020
Single-cell omics analysis reveals functional diversification of hepatocytes during liver regeneration
T Chen, S Oh, S Gregory, X Shen, AM Diehl
JCI insight 5 (22), 2020
482020
Chromatin remodeling of colorectal cancer liver metastasis is mediated by an HGF‐PU. 1‐DPP4 axis
L Wang, E Wang, J Prado Balcazar, Z Wu, K Xiang, Y Wang, Q Huang, ...
Advanced Science 8 (19), 2004673, 2021
162021
Integrated chromatin and transcriptomic profiling of patient-derived colon cancer organoids identifies personalized drug targets to overcome oxaliplatin resistance
KL Tung, KY Chen, M Negrete, T Chen, A Safi, AA Aljamal, L Song, ...
Genes & diseases 8 (2), 203-214, 2021
162021
Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis
K Du, R Maeso-Díaz, SH Oh, E Wang, T Chen, C Pan, K Xiang, RK Dutta, ...
Hepatology 77 (6), 1998-2015, 2023
142023
Aging reduces liver resiliency by dysregulating Hedgehog signaling
R Maeso‐Díaz, GD Dalton, S Oh, K Du, L Tang, T Chen, RK Dutta, ...
Aging Cell 21 (2), e13530, 2022
112022
Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion
NS Giroux, S Ding, MT McClain, TW Burke, E Petzold, HA Chung, ...
Scientific reports 12 (1), 11714, 2022
92022
Hepatocyte smoothened activity controls susceptibility to insulin resistance and nonalcoholic fatty liver disease
T Chen, G Dalton, SH Oh, R Maeso-Diaz, K Du, RA Meyers, C Guy, ...
Cellular and Molecular Gastroenterology and Hepatology 15 (4), 949-970, 2023
42023
Targeting senescent hepatocytes using the thrombomodulin-PAR1 inhibitor vorapaxar ameliorates NAFLD progression
R Maeso-Díaz, K Du, C Pan, CD Guy, SH Oh, T Chen, L Wang, DC Ko, ...
Hepatology 78 (4), 1209-1222, 2023
32023
Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity
NS Giroux, S Ding, MT McClain, TW Burke, E Petzold, HA Chung, ...
BioRxiv, 2020
32020
Su1529 SMOOTHENED DEPENDENT HEDGEHOG SIGNALING ENSURES METABOLIC CONTROL BY MAINTAINING AUTOPHAGY AND PROTECTING AGAINST FERROPTOSIS
JH Jun, T Chen, G Dalton, S Oh, R Maeso-Diaz, R Dutta, K Du, AM Diehl
Gastroenterology 164 (6), S-1317-S-1318, 2023
2023
TARGETING SENESCENT HEPATOCYTES USING THETHBD-PAR1 INHIBITOR VORAPAXAR AMELIORATES NAFLD PROGRESSION
K Du, RM Diaz, P Christopher, CD Guy, SH Oh, T Chen, L Tang, RK Dutta, ...
HEPATOLOGY 76, S80-S81, 2022
2022
TARGETING YAP-MEDIATED HEPATIC STELLATE CELL DEATH SUSCEPTIBILITY AND SENESCENCE FOR TREATMENT OF LIVER FIBROSIS
K Du, RM Diaz, SH Oh, RK Dutta, T Chen, JTA Chi, AM Diehl
HEPATOLOGY 76, S50-S51, 2022
2022
AGING REDUCES LIVER RESILIENCY BY DYSREGULATING HEDGEHOG SIGNALING
R Maeso Diaz, GD Dalton, SH Oh, K Du, L Tang, T Chen, AM Diehl
HEPATOLOGY 74, 103A-103A, 2021
2021
SINGLE CELL RNA SEQUENCING DATA FROM MICE IDENTIFIES INHIBITED HEDGEHOG SIGNALING IN HEPATOCYTES AS A CRITICAL EARLY EVENT IN HUMAN NAFLD
T Chen, GD Dalton, SH Oh, RM Diaz, K Du, RA Myers, SG Gregory, ...
HEPATOLOGY 74, 142A-142A, 2021
2021
A Beautiful Day in the Neighborhood: Application of Single‐Cell Transcriptomics to Unravel Liver Cell Heterogeneity in Diseased Human Livers
T Chen, AM Diehl
Hepatology 74 (2), 547-549, 2021
2021
DYNAMIC EPIGENETIC REPROGRAMMING ENABLES FUNCTIONAL DIVERSIFICATION OF HEPATOCYTES DURING LIVER REGENERATION
T Chen, SH Oh, SG Gregory, X Shen, AM Diehl
HEPATOLOGY 72, 119A-120A, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–17